Riskpilot← Back to searchSign inGet full accessMedicover AB
ABActiveOrg 5590739487Riddargatan 12 A 3trActivities of head offices · NACE 7010Est. 201610-19 employees
Revenue 2024
SEK 11,5M
+3% vs 2023
EBITDA margin
-600.0%
+59% vs 2023
Equity ratio
81.8%
Financial strength
Net profit 2024
SEK 275M
+107% vs 2023
| Revenue | SEK 11,5M | +3% |
| EBITDA | SEK -68,8M | +59% |
| Net profit | SEK 275M | +107% |
| Total assets | SEK 9B | +15% |
| Equity | SEK 7,4B | +11% |
| Employees | — | — |
Legal name
Medicover AB
Org number
5590739487
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
26 augusti 2016
Share capital
SEK 355 229 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall direkt eller indirekt, aktivt verka för en ändamålsenlig samordning och utveckling av den verksamhet som bedrivs i dotterbolag, samt därmed förenlig verksamhet.
Address
Riddargatan 12 A 3tr
Phone
+46840017600
Email
info@medicover.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 6 153 | 10 447 | 10 034 | 10 250 | 11 122 | 11 096 | 11 459 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | — | −38 391 | −58 452 | −75 217 | −90 309 | −112 753 | −166 827 | −166 440 | −68 754 |
| Depreciation & amort. | −0 | — | −0 | — | — | — | — | — | — |
| EBIT | 0 | −38 391 | −58 452 | −75 217 | −90 309 | −112 753 | −166 827 | −166 440 | −68 754 |
| Net financials | — | 1 969 | 313 796 | 121 184 | 110 378 | 133 254 | 122 340 | 288 496 | 343 770 |
| Profit before tax | 0 | −36 422 | 255 345 | 45 966 | 20 069 | 20 501 | −44 487 | 133 152 | 275 016 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −36 422 | 255 345 | 45 966 | 20 069 | 20 501 | −44 487 | 133 152 | 275 016 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 67 | 4 292 881 | 4 755 151 | 5 688 283 | 6 161 060 | 6 467 939 | 6 817 663 | 7 855 968 | 8 995 315 |
| Equity | 67 | 4 237 756 | 4 686 444 | 4 837 913 | 6 140 992 | 6 252 683 | 6 639 715 | 6 657 600 | 7 356 678 |
| Long-term debt | 0 | 32 485 | 33 841 | 0 | 0 | 0 | 0 | 1 131 792 | 1 604 260 |
| Short-term debt | 0 | 22 641 | 34 866 | 850 370 | 20 069 | 225 507 | 177 949 | 55 480 | 34 377 |
| Total debt | — | 55 126 | 68 707 | 850 370 | 20 069 | 225 507 | 177 949 | 1 187 272 | 1 638 637 |
EBITDA margin
-600.0%
This company
15.8%
Market median
-3897% vs market
20162024
Equity ratio
81.8%
This company
38.2%
Market median
+114% vs market
20162024
Return on equity
3.7%
This company
18.4%
Market median
-80% vs market
20162024
Net profit margin
2400.0%
This company
8.1%
Market median
+29530% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-08-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AK Chief Auditor | Chief Auditor | 2022 | — | — |
KJ Chief Auditor | Chief Auditor | 2023 | — | — |
JP Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Celox Holding AB | Company | 55.0% | 55.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Celox Holding AB
Medicover AB (this company)MEDICOVER HOLDING S.A.Midicover Holding S.A.Medicover Holding S.A.Board members of Medicover AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Karin Siwertz | Chief Auditor | 0 companies |
| Kurt Jörgen Lövgren | Chief Auditor | 0 companies |
| John Paul Stubbington | Chief Executive Officer | 0 companies |
| Fredrik Stenmo | Chairman | 0 companies |
| Sonali Asit Chandmal | Board of Directors | 0 companies |
| Carl Fredrik Rågmark | Board of Directors | 0 companies |
| Arno Bohn | Board of Directors | 0 companies |
| Cecil Michael Douglas Flemming | Board of Directors | 0 companies |
| Claudia Camilla Olsson | Board of Directors | 0 companies |
| Anne-Catherine Berner | Board of Directors | 0 companies |
| Robert Af Jochnick | Board of Directors | 0 companies |
| A Margareta J Nordenvall | Board of Directors | 0 companies |
| Jonas Peder Christian af Jochnick | Board of Directors | 0 companies |
| Azita Shariati Mirsaidi | Board of Directors | 0 companies |